Human Stem Cells Search Results


bone marrow  (ATCC)
96
ATCC bone marrow
Bone Marrow, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bone marrow/product/ATCC
Average 96 stars, based on 1 article reviews
bone marrow - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier
human mesenchymal stem cell multi color flow kit  (R&D Systems)
94
R&D Systems human mesenchymal stem cell multi color flow kit
Human Mesenchymal Stem Cell Multi Color Flow Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human mesenchymal stem cell multi color flow kit/product/R&D Systems
Average 94 stars, based on 1 article reviews
human mesenchymal stem cell multi color flow kit - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
human pluripotent stem cell functional identification kit  (R&D Systems)
96
R&D Systems human pluripotent stem cell functional identification kit
Human Pluripotent Stem Cell Functional Identification Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human pluripotent stem cell functional identification kit/product/R&D Systems
Average 96 stars, based on 1 article reviews
human pluripotent stem cell functional identification kit - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier
human mesenchymal stem cell functional identification kit  (R&D Systems)
99
R&D Systems human mesenchymal stem cell functional identification kit
Human Mesenchymal Stem Cell Functional Identification Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human mesenchymal stem cell functional identification kit/product/R&D Systems
Average 99 stars, based on 1 article reviews
human mesenchymal stem cell functional identification kit - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier
proteome profiler array  (R&D Systems)
94
R&D Systems proteome profiler array
Characterization of HS-181 cell line after treatment with zebularine. ( a ) RT-PCR of cardiac markers after treatment with zebularine. Myh7, Myh6, Actc, cTnI and Serca2 present more expression after treatment. ( b ) Immunostaining of treated cells to detect cardiac-specific proteins. Scale bars; 50 μ m. ( c ) Blots of <t>Proteome</t> <t>Profiler</t> Array and the resulting quantification histograms demonstrating inhibition of pluripotency marker expression and ( d ) increased levels of mesodermic proteins after zebularine treatment (black arrows)
Proteome Profiler Array, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/proteome profiler array/product/R&D Systems
Average 94 stars, based on 1 article reviews
proteome profiler array - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
human pluripotent stem cell antibody array  (R&D Systems Hematology)
94
R&D Systems Hematology human pluripotent stem cell antibody array
Bioenergetic modulation counteracts the protumorigenic action of the SU11274. a – b Protein lysates were prepared from untreated controls and Rel3 cells treated with 1 μM SU11274 in spheroid conditions for 7 days. <t>Pluripotent</t> stem cell array has shown expression of all pluripotency markers in Rel3 cells expanded as spheroids. SU11274 treatment further increased level of proteins associated with pluripotency in SU11274-treated cells correlating with their higher tumor initiating properties. Phosphokinase assay screening has shown several active intracellular signaling cascades. Phosphorylated forms of p53 (S392 and S46) were detected in the SU11274-treated cells (lower panel B), which correlates with SU11274 mediated inhibition of cell proliferation. RSK1/2/3 (S380) phosphorylation was increased in SU11274-treated cells. We detected phosphorylation of the following target kinases: ERK1/2 (T202/Y204, T185/Y187), P-RAS40 (T246), Akt 1/2/3 (S473), p38 alpha (T180/Y182), AMPK alpha1 (T183), CREB (S133), GSK-3 alpha/beta(S21/S9), WNK-1 (T60) and HSP60 in both treated and untreated cells
Human Pluripotent Stem Cell Antibody Array, supplied by R&D Systems Hematology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human pluripotent stem cell antibody array/product/R&D Systems Hematology
Average 94 stars, based on 1 article reviews
human pluripotent stem cell antibody array - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
pluripotent stem cell marker antibody panel plus  (R&D Systems)
93
R&D Systems pluripotent stem cell marker antibody panel plus
Bioenergetic modulation counteracts the protumorigenic action of the SU11274. a – b Protein lysates were prepared from untreated controls and Rel3 cells treated with 1 μM SU11274 in spheroid conditions for 7 days. <t>Pluripotent</t> stem cell array has shown expression of all pluripotency markers in Rel3 cells expanded as spheroids. SU11274 treatment further increased level of proteins associated with pluripotency in SU11274-treated cells correlating with their higher tumor initiating properties. Phosphokinase assay screening has shown several active intracellular signaling cascades. Phosphorylated forms of p53 (S392 and S46) were detected in the SU11274-treated cells (lower panel B), which correlates with SU11274 mediated inhibition of cell proliferation. RSK1/2/3 (S380) phosphorylation was increased in SU11274-treated cells. We detected phosphorylation of the following target kinases: ERK1/2 (T202/Y204, T185/Y187), P-RAS40 (T246), Akt 1/2/3 (S473), p38 alpha (T180/Y182), AMPK alpha1 (T183), CREB (S133), GSK-3 alpha/beta(S21/S9), WNK-1 (T60) and HSP60 in both treated and untreated cells
Pluripotent Stem Cell Marker Antibody Panel Plus, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pluripotent stem cell marker antibody panel plus/product/R&D Systems
Average 93 stars, based on 1 article reviews
pluripotent stem cell marker antibody panel plus - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
human mesenchymal stem cell marker antibody panel  (R&D Systems)
94
R&D Systems human mesenchymal stem cell marker antibody panel
Bioenergetic modulation counteracts the protumorigenic action of the SU11274. a – b Protein lysates were prepared from untreated controls and Rel3 cells treated with 1 μM SU11274 in spheroid conditions for 7 days. <t>Pluripotent</t> stem cell array has shown expression of all pluripotency markers in Rel3 cells expanded as spheroids. SU11274 treatment further increased level of proteins associated with pluripotency in SU11274-treated cells correlating with their higher tumor initiating properties. Phosphokinase assay screening has shown several active intracellular signaling cascades. Phosphorylated forms of p53 (S392 and S46) were detected in the SU11274-treated cells (lower panel B), which correlates with SU11274 mediated inhibition of cell proliferation. RSK1/2/3 (S380) phosphorylation was increased in SU11274-treated cells. We detected phosphorylation of the following target kinases: ERK1/2 (T202/Y204, T185/Y187), P-RAS40 (T246), Akt 1/2/3 (S473), p38 alpha (T180/Y182), AMPK alpha1 (T183), CREB (S133), GSK-3 alpha/beta(S21/S9), WNK-1 (T60) and HSP60 in both treated and untreated cells
Human Mesenchymal Stem Cell Marker Antibody Panel, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human mesenchymal stem cell marker antibody panel/product/R&D Systems
Average 94 stars, based on 1 article reviews
human mesenchymal stem cell marker antibody panel - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
human pluripotent stem cell 3 color immunocytochemistry kit  (R&D Systems)
94
R&D Systems human pluripotent stem cell 3 color immunocytochemistry kit
Bioenergetic modulation counteracts the protumorigenic action of the SU11274. a – b Protein lysates were prepared from untreated controls and Rel3 cells treated with 1 μM SU11274 in spheroid conditions for 7 days. <t>Pluripotent</t> stem cell array has shown expression of all pluripotency markers in Rel3 cells expanded as spheroids. SU11274 treatment further increased level of proteins associated with pluripotency in SU11274-treated cells correlating with their higher tumor initiating properties. Phosphokinase assay screening has shown several active intracellular signaling cascades. Phosphorylated forms of p53 (S392 and S46) were detected in the SU11274-treated cells (lower panel B), which correlates with SU11274 mediated inhibition of cell proliferation. RSK1/2/3 (S380) phosphorylation was increased in SU11274-treated cells. We detected phosphorylation of the following target kinases: ERK1/2 (T202/Y204, T185/Y187), P-RAS40 (T246), Akt 1/2/3 (S473), p38 alpha (T180/Y182), AMPK alpha1 (T183), CREB (S133), GSK-3 alpha/beta(S21/S9), WNK-1 (T60) and HSP60 in both treated and untreated cells
Human Pluripotent Stem Cell 3 Color Immunocytochemistry Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human pluripotent stem cell 3 color immunocytochemistry kit/product/R&D Systems
Average 94 stars, based on 1 article reviews
human pluripotent stem cell 3 color immunocytochemistry kit - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
msc verification kit  (R&D Systems)
99
R&D Systems msc verification kit
Bioenergetic modulation counteracts the protumorigenic action of the SU11274. a – b Protein lysates were prepared from untreated controls and Rel3 cells treated with 1 μM SU11274 in spheroid conditions for 7 days. <t>Pluripotent</t> stem cell array has shown expression of all pluripotency markers in Rel3 cells expanded as spheroids. SU11274 treatment further increased level of proteins associated with pluripotency in SU11274-treated cells correlating with their higher tumor initiating properties. Phosphokinase assay screening has shown several active intracellular signaling cascades. Phosphorylated forms of p53 (S392 and S46) were detected in the SU11274-treated cells (lower panel B), which correlates with SU11274 mediated inhibition of cell proliferation. RSK1/2/3 (S380) phosphorylation was increased in SU11274-treated cells. We detected phosphorylation of the following target kinases: ERK1/2 (T202/Y204, T185/Y187), P-RAS40 (T246), Akt 1/2/3 (S473), p38 alpha (T180/Y182), AMPK alpha1 (T183), CREB (S133), GSK-3 alpha/beta(S21/S9), WNK-1 (T60) and HSP60 in both treated and untreated cells
Msc Verification Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/msc verification kit/product/R&D Systems
Average 99 stars, based on 1 article reviews
msc verification kit - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier
sk 1111  (Cook MyoSite Inc)
94
Cook MyoSite Inc sk 1111
Bioenergetic modulation counteracts the protumorigenic action of the SU11274. a – b Protein lysates were prepared from untreated controls and Rel3 cells treated with 1 μM SU11274 in spheroid conditions for 7 days. <t>Pluripotent</t> stem cell array has shown expression of all pluripotency markers in Rel3 cells expanded as spheroids. SU11274 treatment further increased level of proteins associated with pluripotency in SU11274-treated cells correlating with their higher tumor initiating properties. Phosphokinase assay screening has shown several active intracellular signaling cascades. Phosphorylated forms of p53 (S392 and S46) were detected in the SU11274-treated cells (lower panel B), which correlates with SU11274 mediated inhibition of cell proliferation. RSK1/2/3 (S380) phosphorylation was increased in SU11274-treated cells. We detected phosphorylation of the following target kinases: ERK1/2 (T202/Y204, T185/Y187), P-RAS40 (T246), Akt 1/2/3 (S473), p38 alpha (T180/Y182), AMPK alpha1 (T183), CREB (S133), GSK-3 alpha/beta(S21/S9), WNK-1 (T60) and HSP60 in both treated and untreated cells
Sk 1111, supplied by Cook MyoSite Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sk 1111/product/Cook MyoSite Inc
Average 94 stars, based on 1 article reviews
sk 1111 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
normal human adiposederived mscs  (ATCC)
96
ATCC normal human adiposederived mscs
Bioenergetic modulation counteracts the protumorigenic action of the SU11274. a – b Protein lysates were prepared from untreated controls and Rel3 cells treated with 1 μM SU11274 in spheroid conditions for 7 days. <t>Pluripotent</t> stem cell array has shown expression of all pluripotency markers in Rel3 cells expanded as spheroids. SU11274 treatment further increased level of proteins associated with pluripotency in SU11274-treated cells correlating with their higher tumor initiating properties. Phosphokinase assay screening has shown several active intracellular signaling cascades. Phosphorylated forms of p53 (S392 and S46) were detected in the SU11274-treated cells (lower panel B), which correlates with SU11274 mediated inhibition of cell proliferation. RSK1/2/3 (S380) phosphorylation was increased in SU11274-treated cells. We detected phosphorylation of the following target kinases: ERK1/2 (T202/Y204, T185/Y187), P-RAS40 (T246), Akt 1/2/3 (S473), p38 alpha (T180/Y182), AMPK alpha1 (T183), CREB (S133), GSK-3 alpha/beta(S21/S9), WNK-1 (T60) and HSP60 in both treated and untreated cells
Normal Human Adiposederived Mscs, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/normal human adiposederived mscs/product/ATCC
Average 96 stars, based on 1 article reviews
normal human adiposederived mscs - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

Image Search Results


Characterization of HS-181 cell line after treatment with zebularine. ( a ) RT-PCR of cardiac markers after treatment with zebularine. Myh7, Myh6, Actc, cTnI and Serca2 present more expression after treatment. ( b ) Immunostaining of treated cells to detect cardiac-specific proteins. Scale bars; 50 μ m. ( c ) Blots of Proteome Profiler Array and the resulting quantification histograms demonstrating inhibition of pluripotency marker expression and ( d ) increased levels of mesodermic proteins after zebularine treatment (black arrows)

Journal: Cell Death & Disease

Article Title: Zebularine regulates early stages of mESC differentiation: effect on cardiac commitment

doi: 10.1038/cddis.2013.88

Figure Lengend Snippet: Characterization of HS-181 cell line after treatment with zebularine. ( a ) RT-PCR of cardiac markers after treatment with zebularine. Myh7, Myh6, Actc, cTnI and Serca2 present more expression after treatment. ( b ) Immunostaining of treated cells to detect cardiac-specific proteins. Scale bars; 50 μ m. ( c ) Blots of Proteome Profiler Array and the resulting quantification histograms demonstrating inhibition of pluripotency marker expression and ( d ) increased levels of mesodermic proteins after zebularine treatment (black arrows)

Article Snippet: Protein expression profiles were assayed using the specific human pluripotent Stem Cell array kit ‘Proteome Profiler Array' (R&D Systems Europe, Abingdon, UK; ARY010) following the manufacturer's instructions.

Techniques: Reverse Transcription Polymerase Chain Reaction, Expressing, Immunostaining, Inhibition, Marker

Bioenergetic modulation counteracts the protumorigenic action of the SU11274. a – b Protein lysates were prepared from untreated controls and Rel3 cells treated with 1 μM SU11274 in spheroid conditions for 7 days. Pluripotent stem cell array has shown expression of all pluripotency markers in Rel3 cells expanded as spheroids. SU11274 treatment further increased level of proteins associated with pluripotency in SU11274-treated cells correlating with their higher tumor initiating properties. Phosphokinase assay screening has shown several active intracellular signaling cascades. Phosphorylated forms of p53 (S392 and S46) were detected in the SU11274-treated cells (lower panel B), which correlates with SU11274 mediated inhibition of cell proliferation. RSK1/2/3 (S380) phosphorylation was increased in SU11274-treated cells. We detected phosphorylation of the following target kinases: ERK1/2 (T202/Y204, T185/Y187), P-RAS40 (T246), Akt 1/2/3 (S473), p38 alpha (T180/Y182), AMPK alpha1 (T183), CREB (S133), GSK-3 alpha/beta(S21/S9), WNK-1 (T60) and HSP60 in both treated and untreated cells

Journal: BMC Cancer

Article Title: Tyrosine kinase inhibitor SU11274 increased tumorigenicity and enriched for melanoma-initiating cells by bioenergetic modulation

doi: 10.1186/s12885-016-2341-y

Figure Lengend Snippet: Bioenergetic modulation counteracts the protumorigenic action of the SU11274. a – b Protein lysates were prepared from untreated controls and Rel3 cells treated with 1 μM SU11274 in spheroid conditions for 7 days. Pluripotent stem cell array has shown expression of all pluripotency markers in Rel3 cells expanded as spheroids. SU11274 treatment further increased level of proteins associated with pluripotency in SU11274-treated cells correlating with their higher tumor initiating properties. Phosphokinase assay screening has shown several active intracellular signaling cascades. Phosphorylated forms of p53 (S392 and S46) were detected in the SU11274-treated cells (lower panel B), which correlates with SU11274 mediated inhibition of cell proliferation. RSK1/2/3 (S380) phosphorylation was increased in SU11274-treated cells. We detected phosphorylation of the following target kinases: ERK1/2 (T202/Y204, T185/Y187), P-RAS40 (T246), Akt 1/2/3 (S473), p38 alpha (T180/Y182), AMPK alpha1 (T183), CREB (S133), GSK-3 alpha/beta(S21/S9), WNK-1 (T60) and HSP60 in both treated and untreated cells

Article Snippet: Proteome profile of the melanosphere cells cultured for 7 days in the presence of 1 μM SU11274 was evaluated by the Proteome ProfilerTM Human Phospho-Kinase Antibody Array and the Human Pluripotent Stem Cell Antibody Array (R&D SystemsTM Inc., Minneapolis MN).

Techniques: Expressing, Inhibition, Phospho-proteomics